These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6493360)

  • 21. Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.
    Maślińska D
    Acta Physiol Pol; 1984; 35(2):137-40. PubMed ID: 6443171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
    Benmansour S; Brunswick DJ
    Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction.
    Dănilă MD; Privistirescu AI; Mirica SN; Sturza A; Ordodi V; Noveanu L; Duicu OM; Muntean DM
    Can J Physiol Pharmacol; 2015 Sep; 93(9):819-25. PubMed ID: 26322912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological and receptor studies in rat brain: effects of clorgyline.
    Campbell IC; Gallager DW; Hamburg MA; Tallman JF; Murphy DL
    Eur J Pharmacol; 1985 May; 111(3):355-64. PubMed ID: 2990957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of intracerebroventricular injection of dopamine after selective MAO inhibition in rats.
    Pazos A; Mediavilla A; Flórez J
    Neuropharmacology; 1982 Apr; 21(4):317-22. PubMed ID: 6283412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic clorgyline treatment enhances release of norepinephrine following sympathetic stimulation in the rat.
    Finberg JP; Kopin IJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):236-42. PubMed ID: 3713870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat.
    Finberg JP; Gross A; Bar-Am O; Friedman R; Loboda Y; Youdim MB
    Br J Pharmacol; 2006 Nov; 149(6):647-56. PubMed ID: 17016505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.
    Gutkind JS; Kazanietz M; Enero MA
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):370-5. PubMed ID: 3736681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation.
    Lipper S; Murphy DL; Slater S; Buchsbaum MS
    Psychopharmacology (Berl); 1979 Apr; 62(2):123-8. PubMed ID: 111274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
    Staub RA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.
    Aulakh CS; Hill JL; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1988; 95(3):313-7. PubMed ID: 3137616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. REM sleep suppression induced by selective monoamine oxidase inhibitors.
    Cohen RM; Pickar D; Garnett D; Lipper S; Gillin JC; Murphy DL
    Psychopharmacology (Berl); 1982; 78(2):137-40. PubMed ID: 6817370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'-monophosphate systems in rat brain.
    Cohen RM; Ebstein RP; Daly JW; Murphy DL
    J Neurosci; 1982 Nov; 2(11):1588-95. PubMed ID: 6292376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.
    Cohen RM; Campbell IC; Yamaguchi I; Pickar D; Kopin IJ; Murphy DL
    Eur J Pharmacol; 1982 May; 80(1):155-60. PubMed ID: 6284529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.